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a blood volunie less than 3 mL, and 2893 (40.1%) 
bottles received a blood volume larger than 10 mL. 
It  is striking that only 14.3% of the bottles met the 
optimal volume criterion and that roughly half of the 
bottles were inadequately filled. 
In a siniilar audit that we performed earlier [3],  
we found the 4.5% false-positive rate to be clearly 
associated with overfilling, and this phenomenon has 
also been reported for analogous blood culture systems 
[2].  In the present study, we found false positives in 
57 (2.0%) of 2839 overfilled bottles but no false 
positives in the 1028 bottles containing the optimal 
blood volume. Apparently, the revised software in the 
BACTEC 9240 analyzer (version 3.61F in the present 
study) compensates for false-positive readings due to 
overfilling. 
Of  more concern is the number of underfilled 
bottles. The direct-draw technique does not allow the 
user to control the volume of blood by comparing the 
blood-broth column height with the volume indications 
on the product label. When queried about this finding, 
the phlebotomists in our hospital pointed to the lack of 
a well-defined ‘endpoint’ that could indicate when to 
withdraw the bottle from the needle-holder. Nearly 
one third of the phlebotomists stated that they did not 
withdraw the bottle until complete depletion of the 
vacuum, a procedure that may result in overfilling. In 
the case of a difficult venipuncture, however, they tend 
to withdraw the bottles rather fast to ensure filling of 
the remaining bottle and eventual other blood-collect- 
ing tubes, an action that may result in underfilling. 
Underfilling may have been due to the instructions 
as stated 011 the label: ‘range 3-10 niL‘ and ‘optimal 
8-10 i d ’ .  This asymmetry is confusing, as it suggests 
that the lower volume limit is less crucial than the upper 
one. Furthermore, there was much confusion concern- 
ing the volume range, with only 25 (16.9%) of the 
interviewed phlebotomists being aware of the correct 
optimal volume. In recent years, the layout of the 
product label on the BACTEC”LU4/F bottles has 
been changed several times, with an extension of the 
reconimended blood volume. We argue that the label 
should clearly state that the optimal volume of blood is 
8-1 0 niL/bottle and that 3 mL and 1 0  mL are the limits 
of acceptable blood volumes for each bottle. Further, 
phlebotomists should be notified of the appropriate 
blood volumes for culture. 
Repeatedly, we demonstrated a poor compliance 
rate in filling BACTECP‘ “’/F bottles. The direct-draw 
blood sampling technique of these bottles has to be 
evaluated and a filling endpoint has to be defined, in 
order to give appropriate directives to achieve com- 
pliance with the reconimended blood volume to be 
added to the blood culture bottle. The present study 
indicates that volumes of blood for culture should be 
monitored routinely as a quality assurance measure. 
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Long-term follow-up of patients with catheter-related 
bacteremia treated without catheter removal 
Clin Mirvohiol Infect 1998; 4: 472-476 
It  has been demonstrated that central venous catheter- 
related bactereinia (CRB) can be treated without 
catheter renioval under certain clinical circumstances 
by the use of local intracatheter antibiotics (antibiotic- 
lock technique) plus systemic antibiotics 11-81, This 
conservative approach permits preservation of the 
vascular access in patients who require it for long 
periods of time, such as those receiving oncologic 
treatment, home parented nutrition or periodic 
hemodialysis sessions 19-1 11. 
The advantages of maintaining the catheter are 
well established in terms of cost and patient comfort. 
There dre questions, however, concerning the possible 
development of long-term septic complications, such 
as endocarditis or spondylitis [12-141, derived from 
maintaining an infected device until microbial eradica- 
tion has been completed. Moreover. there are no 
reports that conclusively describe the functionality and 
duration of- sustained catheters. The aini of this study 
was to analyze the outcoine of a cohort of patients who 
had experienced an episode of CXB and were treated 
without catheter removal, in order to evaluate the 
patency and usefulnesc of sustained catheters and the 
emergence of late infectious complications. 
During a 41-month period (October 1990 to 
February 1994), we prospectively followed up all 
patients with a central venous catheter (Pernicath) 
Concise  C o m m u n i c a t i o n s  41 3 
implanted for hemodialysis purposes in the nephrology 
unit of an 850-bed university hospital. All cases were 
in the end stage of chronic renal disease and needed 
periodic hemodialysis treatment. The Permcath Quinton 
(A.H. Robbins Co., USA) is a 28-cm, radiopaque, 
double-lumen silicone rubber catheter with a Dacron 
felt cuff. AU catheters were inserted into the internal 
jugular vein and were used only for hemodialysis. 
Catheters were implanted and removed under sterile 
conditions in the operating room. CRB was suspected 
when a patient in whom a Permcath catheter had 
been inserted developed unexplained fever (temperature 
>37.5"C) and/or clinical signs of infection in the 
absence of other documented infections. Diagnosis of 
CRB was established on the basis of microbiological 
criteria, i.e. quantitative culture of blood samples 
(Schottmuller technique) simultaneously obtained from 
a peripheral vein and through each catheter lumen. 
Bacteremia was considered to be catheter-related 
when (1) the same microorganism was isolated from 
one or more peripheral blood cultures and one or 
two quantitative blood cultures obtained through the 
catheter, (2) there was a fourfold increase or more 
in bacteria colony counts (CFU/mL) between the 
quantitative blood cultures obtained via the catheter 
and via the peripheral vein, and (3) no primary 
infective site other than the catheter could be identified 
clinically or bacteriologically. Bacteremia was classified 
as unrelated to the central venous catheter when 
bacterial counts obtained via the catheter were not 
fourfold higher than identical bacterial colonies in 
the peripheral blood specimen. The accuracy of this 
cut-off limit for positivity was assessed in a previous 
study by our group [IS]. 
CRB treatment consisted of simultaneous anti- 
biotic administration locally intracatheter (antibiotic- 
lock technique), and intravenously, as has been pre- 
viously described [ 1 11. After blood cultures were drawn 
from the catheter and from a peripheral vein, patients 
who appeared to have CRB were empirically given 
ciprofloxacin as initial antimicrobial therapy. Thereafter 
and according to bacteriologic results, antibiotic was 
discontinued or modified. The antibiotics administered 
were vancomycin (1 g/week) or ciprofloxacin (200 mg) 
at the end of each hemodialysis session, depending on 
the bacterial isolates. Antibiotics were given by 4-h 
continuous infusion via the hemodialysis catheter (half 
of the dose through each lumen). In addition, using the 
antibiotic-lock technique, 2 mL of a solution of 
vancomycin or ciprofloxacin, 100 mg/L in 5% sodium 
heparin, was injected into each catheter lumen between 
two hemodialysis sessions. Antibiotic administration 
lasted for 15 days. 
The exclusion criteria for conservative manage- 
ment of a CRB episode were: phlebitis and/or purulent 
exudate, presence of foreign bodies such as prosthetic 
heart valves, vascular grafts, pacemakers or/and ortho- 
pedic prostheses, sepsis with clinical complications, 
such as septic shock, disseminated mtravascular coagu- 
lation and/or respiratory insufficiency, pulmonary 
embolism, infective endocarditis, and positive blood 
cultures for yeast. It was also intended that patients with 
persistent bacteremia 48-72 h after starting therapy 
should be excluded from conservative treatment; thus, 
quantitative blood cultures were performed at 48-72 h, 
and after finalizing treatment. 
Beginning from the time that .in episode of CRB 
had been diagnosed and treated, the patients were 
prospectively followed up. Every time that a patient had 
fever or complained of any clinical sign suggestive of 
infection, a complete evaluation was done. The study 
protocol consisted of a careful physical examination, 
including insertion site and tunnelization, hemogram 
and biochemistry analysis, peripheral and catheter 
quantitative blood cultures, urine culture when feasible, 
culture of all secretions, and other complementary 
explorations (e.g. echocardiography, computed tomo- 
graphy scan) depending on clinical manifestations. 
When a patient no longer required the catheter, 
because an arteriovenous fistula had developed or the 
function of a transplanted kidney had become effective, 
the catheter was aseptically rem0vt.d in the operating 
room. The extracted catheters were cultured by the 
semiquantitative method proposed by Maki et a1 [16]. 
The patients studied were followed up whether their 
catheters remained in place or not. The follow-up 
period was completed in May 1994.. 
Over the study period, implanted jugular catheters 
were applied for hemodialysis in 185 patients. Of  these, 
37 patients (23 males; mean age 54.5 years, range 
22-81) experienced a total of 42 episodes of CRB. 
This figure represents 0.13 episodes of C R B  per 100 
days of indwelling catheter use. The microorganisms 
responsible were: Staphylococcus epidermidis (20 episodes), 
Staphylococcus aureus (13), Pseudoinonas aeruginosa (€9, 
Enterococcus faecalis (l), Corynebactcriurn jeikenum (l), 
Stauotrophomonas maltophila (l), and Klebsiella pneu- 
moniae (1). 
Two patients presented exclusion criteria for 
conservative management of CEU3: one had a knee 
prosthesis (Staphylococcus aureus CRB) and other pre- 
sented initial hypotension (I? aeruginosa CRB). All cases 
managed with the catheter in place were afebrile after 
24-48 h of treatment, with negative quantitative blood 
cultures. 
At the end of the study (May 1994), 10 patients 
had died (four acute myocardial infarction, two neuro- 
logic stroke, one mesenteric ischemia, one multiple 
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Table 1 Patients with more than one episode of catheter-related sepsis 
Echocardiography Outcome Etiologya Etiologyh Interval (days) 
P nerngimsa J? nrru$ittosa 85 Normal Transplant 
Heart failurc I? aeni'Tinosa J? aWUglllCJSd 65 Normal 
A-V fistula S. tyiderniidir S .  epiderniidis 360 Nortnal 
Staplrylococcirr aiireii3 S .  epiderniidis 520 Myocardiopathy A-V fistula 
A-V fistula Staphylocorcirj aweus Staphylococrtis aiireiu 335 Nornial 
.'First episode, hSccond episodc. 
A-V. arteriovenous. 
Staphylococcus aiirriis Death 
myeloma, one upper gastrointestinal bleeding, and one 
peritonitis), five had received a successful kidney 
transplant and 20 remained on intermittent hemo- 
dialysis by arteriovenous fistula. The mean duration of 
the follow-up period for each patient was 20.5 months 
(range 2-44 months). After the initial episode of CRB, 
the median duration of the time for which the catheter 
remained in place was 90 days (range 16-670 days). 
Five patients presented a second episode of CKB 
after a mean infection-free interval of 5.3 months 
(range 1-8 months). In Table 1, we show the etiology 
of the two episodes, the interval of time between them, 
echocardiography results and the final outcome of 
follow-up in these patients. These second episodes of 
C R B  were considered to be new and not relapses, 
because of the extended length of the infection- 
free period and the different microorganisms isolated 
None of the patients developed infectious com- 
plications or distant septic metastasis that could be 
associated with the episode of CRB. An echocardio- 
graphic study was performed a t  least once in 18 
patients. The five patients who received a kidney 
transplant suffered eight episodes of infection unrelated 
to the catheter: five were infections of the urinary tract 
caused by Esclierichia rul i  and/or K. pneurnouiae, and 
three were episodes of cytoinegalovirus disease. 
None of the catheters treated conservatively had to 
be removed because of infection. All maintained 
patency and usefulness until they were removed when 
hemodialysis became unnecessary; at that time all had 
a negative tip culture. 
The object of this report is not to emphasize the 
short-term efficacy of conservative CKB antibiotic 
treatment applied under certain clinical circuinstances 
that suggest it, as in patients who need long-term 
central venous access. At the present time, this conser- 
vative approach is well accepted in the literature [I-111. 
For the initial, empirical treatment, we chose 
ciprofloxacin because of its broad coverage against 
Gram-positive cocci and Gram-negative bacilli. When 
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a Gram-positive microorganism was identified, anti- 
biotic treatment was shifted to vancomycin. Both 
antibiotics are stable at 37°C for more than 72 h, and 
at the concentrations used we have not observed 
precipitation with heparin. 
Two patients with Staphylococcus aureus CKB died 
from strokes. Although neurologic manifestations are 
frequent in Staphylococcus aureus endocarditis, neuro- 
logic involvement usually occurs in the acute phase of 
endocarditis, concomitantly with septic manifestations 
and cardiac valve destruction [18, 191. Echocardio- 
grams were not performed in these two patients 
because they appeared well. Stroke developed suddenly 
without other clinical signs of infection and after a long 
interval from the CKB episode, 11  and 2 months 
respectively. We reasonably excluded infectious endo- 
carditis in these patients, who frequently present 
with stroke, related to renal failure and hemodialysis. 
During the follow-up period, 18 echocardiograms 
were performed (nine Staplzylococcur aweus CKB, seven 
S. epidevmidis. one I? aevugiriosa and one Corynebacteriuni 
sp.), and no data suggestive of endocarditis were found. 
The absence of complications in our series, and the 
pernieability of the catheter for the duration of its 
application, strongly argues in favor of the conservative 
management of C R B  in these patients. Five patients 
(14%) developed a second episode of CKB that we 
considered unrelated to the initial episode because of 
the long infection-free period between episodes [I 71. 
In three of these patients we could not unequivocally 
ensure that the second episodes were not actually 
relapses of infection because we did not perform an 
epideniiologic typing of the microorganisms isolated 
and the antibiotic susceptibility pattern did not permit 
a firm conclusion. Nevertheless, these second episodes 
also evolved favorably with a new course of conser- 
vative antibiotic therapy. 
Benerza et a1 [7] reported that 61% of C X B  
cases in cancer patients were successfully treated with 
antibiotics. In a large series of C R B  caused by 
coagulase-negative staphylococci, Raad et a1 [20] 
C o n c i s e  C o m m u n i c a t i o n s  475 
observed no acute infectious complications in the 
treatment of bacteremia while maintaining the catheter 
in place. However, in this retrospective study, the 
authors found 20% of recurrences in the patients in 
whom the catheter was not changed. In both these 
studies [7,20] the antibiotic treatment for bacteremia 
consisted of only intermittent administration of the 
drugs; efforts were not made to sterilize the catheter 
locally, as in the antibiotic-lock technique. 
Treatment of Hickman catheter-related sepsis has 
been accomplished successfully using the antibiotic- 
lock technique [21]. Although repetitive episodes of 
C R B  are frequent in patients with prolonged in- 
dwelling catheterization, antibiotic lock has shown to 
be useful and free from complications when patient 
selection criteria are appropriate, in both the short 
and long term. Marr et a1 [22] have described their 
experience on the advisability of maintaining the 
infected catheter in hemodialysis patients with CRB. 
They report that only 12 catheters in 62 episodes of 
bacteremia (1 9%) were salvaged. This strongly contrasts 
with the experience presented here, but there are many 
differences between the two studies. In contrast to the 
work of Marr et a1 [22], we confirmed all episodes 
of CFU with paired quantitative blood cultures, and 
all catheters removed during follow-up were micro- 
biologically assessed to confirm catheter infection or 
cure. In our patients we used the antibiotic-lock 
technique to achieve high concentrations of antibiotics 
within the catheter during the interdialysis period. 
Patients on hemodialysis are given low doses of 
antibiotics because of renal failure. In this situation the 
catheter is briefly in contact with the frequently 
administered antibiotic only once a week. The fact that 
no attempts were made to sterilize the catheter could 
explain the low success rate in this study as compared 
to our results. 
Although this is a prospective cohort study without 
a comparison group, we believe that our results are 
useful for clinicians and investigators involved in the 
management of catheterized patients in hemodialysis 
units. Our follow-up included a large number of 
patients who were examined regularly by the same 
medical staff over a long period of time. Nevertheless, 
to define the safety of conservative management of 
CRB episodes in other clinical settings, with different 
patient populations and types of catheters, more 
experience is needed. 
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